04/26/2024
7:48 AM | Anika Therapeutics (Filer)
| Form 10-K/A | |
04/05/2024
11:21 AM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
03/19/2024
4:23 PM | Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:20 AM | Anika Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
3:10 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
7:01 PM | Anika Therapeutics (Issuer)
Levitz Michael L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:02 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/12/2024
7:03 PM | Anika Therapeutics (Issuer)
Colleran David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:04 PM | Anika Therapeutics (Issuer)
Blanchard Cheryl R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
6:30 PM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D/A | |
02/26/2024
8:00 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
10:09 AM | Anika Therapeutics (Subject)
Trigran Investments, Inc. (Filed by)
| Form SC 13G/A | |
01/24/2024
1:27 PM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/22/2024
9:52 AM | Anika Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024
8:29 AM | Anika Therapeutics (Filer)
| Form S-8 POS | |
01/19/2024
3:52 PM | Anika Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/12/2024
3:35 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 3/A | |
11/02/2023
3:11 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
1:34 PM | Anika Therapeutics (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
09/21/2023
6:55 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/11/2023
5:01 AM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D/A | |
08/17/2023
7:00 AM | Anika Therapeutics (Subject)
Caligan Partners LP (Filed by)
| Form SC 13D | |
08/08/2023
4:15 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2023
4:18 PM | Anika Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/26/2023
3:54 PM | Anika Therapeutics (Issuer)
Nunes Anne (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/21/2023
3:50 PM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2023
4:15 PM | Anika Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/01/2023
4:22 PM | Anika Therapeutics (Filer)
| Form ARS | |
05/01/2023
4:18 PM | Anika Therapeutics (Filer)
| Form DEF 14A | |
05/01/2023
4:20 PM | Anika Therapeutics (Filer)
| Form DEFA14A | |
04/28/2023
7:00 AM | Anika Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
